News | June 06, 2022
Merck’s pembrolizumab demonstrates improvement in distant metastasis
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Auld is a seasoned Financial Executive with over 30 years of relevant experience
The product will be launched by NATCO's commercial partner Viatris.
Subscribe To Our Newsletter & Stay Updated
